Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040598
Filing Date
2023-08-09
Accepted
2023-08-09 16:14:03
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-20230630.htm   iXBRL 10-Q 2501583
2 EX-31.1 life-ex31_1.htm EX-31.1 14051
3 EX-31.2 life-ex31_2.htm EX-31.2 14160
4 EX-32.1 life-ex32_1.htm EX-32.1 10160
5 EX-32.2 life-ex32_2.htm EX-32.2 9464
  Complete submission text file 0000950170-23-040598.txt   7968280

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230630_pre.xml EX-101.PRE 260358
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT life-20230630_def.xml EX-101.DEF 148759
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230630.xsd EX-101.SCH 40944
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT life-20230630_cal.xml EX-101.CAL 49177
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230630_lab.xml EX-101.LAB 381674
43 EXTRACTED XBRL INSTANCE DOCUMENT life-20230630_htm.xml XML 1443992
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 231155306
SIC: 2836 Biological Products, (No Diagnostic Substances)